This revolutionary class of medications was initially developed for the treatment of type 2 diabetes but has gained significant attention for weight loss and other health benefits
In clinical trials, up to 29% of people taking Zepbound for weight loss experienced nausea, and 18% reported it with Mounjaro for diabetes
The main navigation connects visitors to the product catalog, research blog, peptide calculators, supplier resources, discount-code pages, partner application, privacy policy, shipping policy, terms, disclaimer, and contact page
Because planning, logistics and distribution data are connected on a unified platform, changes in demand are flagged early to supply chain planners
doi:10.1056/NEJMoa1607141 13Husain M, Birkenfeld AL, Donsmark M, et al